Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

Overview of attention for article published in JACC: CardioOncology, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 3 posts from 1 blogs.

Cardiovascular disease related to immune therapy: JACC: CardioOncology special focus issue

SPECIALTIES, 28 Feb 2023

Cardiovascular Disease Related to Immune Therapy: JACC: CardioOncology Special Focus Issue – JACC…

Review | Cardiovascular complications of immune checkpoint inhibitors for cancer.

SPECIALTIES, 06 Sep 2022

Cardiovascular complications of immune checkpoint inhibitors for cancer – European Heart…

Retrospective Cohort Study: Incidence of major adverse cardiac events with immune checkpoint inhibitors.

SPECIALTIES, 13 Jun 2022

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.